Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases

Published:2023-09 Issue: Volume:257 Page:115535
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jiang Die,Xu Ting,Zhong Lei,Liang Qi,Hu Yonghe,Xiao Wenjing,Shi Jianyou^ORCID

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Sichuan Provincial Administration of Traditional Chinese Medicine

Natural Science Foundation of Sichuan Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference136 articles.

1. VEGF in signaling and disease: beyond discovery and development;Apte;Cell,2019

2. Structure and function of VEGF receptors;Stuttfeld;IUBMB Life,2009

3. Vascular-specific growth factors and blood vessel formation;Yancopoulos;Nature,2000

4. Vascular growth factors and lymphangiogenesis;Jussila;Physiol. Rev.,2002

5. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs;Zhang;Eur. J. Med. Chem.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity;Frontiers in Physiology;2024-06-13

2. Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023);Bioorganic Chemistry;2024-05

3. Novel artemisinin derivative P31 inhibits VEGF-induced corneal neovascularization through AKT and ERK1/2 pathways;Heliyon;2024-04

4. Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration;International Journal of Nanomedicine;2024-02

5. Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy;Theranostics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3